Skip to content

MOHFW revises Development Methodology vide New Drugs and Clinical Trials (Amendment) Rules, 2023

Content reader

Listen to this article

Ready to read this article aloud.
MOHFW revises Development Methodology vide New Drugs and Clinical Trials (Amendment) Rules, 2023

On 13-3-2023, the Ministry of Health and Family Welfare notified the New Drugs and Clinical Trials (Amendment) Rules, 2023 to amend the New Drugs and Clinical Trials Rules, 2019. The provisions came into force on 13-3-2023.

First Schedule, Para 3 (1) (b) relating to Development Methodology has been revised:

Previous

Now

The detailed requirements of non-clinical studies have been specified in the Second Schedule.

The general requirements of non- clinical studies are specified in the Second Schedule.

The following testing methods to assess the safety and efficacy of a new drug or investigational new drug now includes the following:

  1. Cell- based assay

  2. Organ chips and micro physiological systems

  3. Sophisticated computer modeling

  4. Other human biology-based test methods

  5. Animal Studies

WhatsApp LinkedIn

0 replies

Leave a Reply

Your email address will not be published. Required fields are marked *.

This site uses Akismet to reduce spam. Learn how your comment data is processed.